000 01158nam##2200265za#4500
0019.615264
003CaOODSP
00520210615101042
007ta
008150406|2000||||xxc|||||     f|0| 0 eng|d
020 |a0-662-29197-2
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH42-2/67-21-2000E
1101 |aCanada. |bHealth Products and Food Branch.
24510|aDerivation and characterization of cell substrates used for production of biotechnological/biological products|cIssued by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use.
260 |aOttawa - Ontario : |bHealth Canada. |c2000.
300 |aii, 17p. ; |c28 cm.
4901 |aTherapeutic Products Directorate guidelines|vICH Topic Q5D
563 |aLoose-leaf
590 |a01-08|b2001-02-23
69007|aBiotechnology|2gcpds
69007|aBiochemical products|2gcpds
7760#|tDerivation and characterization of cell substrates used for production of biotechnological / biological products |w(CaOODSP)9.573963
830#0|aTherapeutic Products Directorate guidelines ;|vICH Topic Q5D|w(CaOODSP)9.514732